Viewing Study NCT07190261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:32 PM
Ignite Modification Date: 2026-02-22 @ 10:36 PM
Study NCT ID: NCT07190261
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2025-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Sponsor: Bing Han
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autoimmune Hemolytic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autoimmune Hemolytic Anemia View
None Enatumab View
None Single-arm phase 2 prospective View